Healthy Volunteers Clinical Trial
Official title:
Diet-Induced-Obesity Resistant Phenotypes in Humans
Background:
- Obesity is the result of many factors, including genetics and lifestyle, such as
over-eating high-calorie foods and not being physically active. Obesity affects approximately
one third of adults in the United States. Researchers often study individuals who are already
overweight and obese, but another approach is to examine people who stay thin despite eating
whatever they want and not exercising. Studying these thin individuals will enhance
understanding of why some people become obese and others do not, which may lead to novel
treatments for obesity.
Objective:
- To study the metabolism, body composition, body temperature, physical activity, and blood
chemistries of healthy lean adults before and after adding 1,000 extra Calories per day to
their normal diet.
Eligibility:
- Healthy adults, 30 to 50 years of age, who have never been overweight after adolescence,
who are currently weight-stable, sedentary, and eating without restrictions.
Design:
- The entire study will take about 9 weeks and will include the following outpatient and
inpatient visits:
<TAB>- Outpatient screening visit and monitoring: Physical examination and blood test at
screening; then, one week of physical activity monitoring (e.g., with a pedometer-like device
called an accelerometer) and completing a food diary.
<TAB>- Baseline inpatient visit (5 days): Volunteers will eat a normal diet to maintain body
weight. Energy expenditure, body composition, physical fitness, activity level, and eating
behavior will be measured. Urine and blood samples will be taken. Volunteers may go home for
the weekend or stay at the metabolic clinical research unit (MCRU).
<TAB>- Inpatient feeding week 1 (5 days): Volunteers will eat a normal diet plus milkshakes
for added calories. All the same measurements during the baseline week visit will be
repeated.
<TAB>- Outpatient feeding weeks 2 3: Volunteers will eat breakfast at the MCRU everyday for
the next 2 weeks and take prepared meals home with them (volunteers may also stay at the MCRU
for the 2 weeks if they prefer). Volunteers will drink a non-radioactive (heavy) water called
doubly labeled water to measure energy expenditure in their normal living environment Daily
urine samples will be collected.
<TAB>- Inpatient feeding week 4 (5 days): Volunteers will continue eating a normal diet plus
milkshakes for added calories. This stay and measurement is identical to inpatient feeding
week 1.
- Volunteers will be contacted at 6 and 12 months to assess any changes in body weight, diet,
and physical activity.
While many obesity studies focus on the individuals who are already overweight and obese, a
complementary approach to understand such a common disease is to define the mechanisms which
allow some lean individuals to resist weight gain. The predominant cause of human obesity is
the inheritance of genes favoring fat storage and efficient energy utilization interacting
with an obesogenic environment, characterized by readily available, energy-dense food and
sedentary lifestyle. However, a persistent percentage (about 30%) of the US adult population
remains thin (BMI <23 kg/M(2)). While some of these individuals maintain their weight by
vigilantly controlling their diet, exercising or taking medication(s), others may have the
ability to remain thin despite an excessive energy intake and without volitional exercise. To
identify these individuals and define their phenotypes will provide unique insights into
energy and body weight homeostasis, and may yield novel approaches for treating obesity.
In this natural history protocol, we will recruit and characterize a cohort of
constitutionally lean and healthy adult volunteers (age 25-50, BMI 18.5-25 kg/M(2)) who do
not have pathological or exogenous factors that are known to stimulate energy expenditure,
suppress food intake, or decrease absorption. We will recruit volunteers who are
weight-stable, sedentary, and non-restrictive eaters, characterize their free-living dietary
and physical activity energy expenditure using food records and portable accelerometers,
respectively. Using an inpatient controlled setting, we will carefully characterize the
details of their 24-hr energy metabolism, body composition, core and skin temperatures, and
blood chemistries while they are on a one-week metabolic diet adjusted to maintain his/her
body weight (baseline) vs. another week of higher energy intake level (1000 extra kcal per
day above their baseline). Overfeeding will continue for two more weeks in the outpatient
setting with all meals provided by our metabolic kitchen, followed by the fourth week of
overfeeding and repeated measurements back in the inpatient setting. We hypothesize that
spontaneous changes in energy expenditure and/or calorie intake may differ between
individuals, and such difference may explain the ability for some to resist body gain. The
accruals of humans with obesity-resistant phenotypes will significantly enhance our
understanding of the mechanisms of energy homeostasis and identify potential novel regulators
for controlling obesity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |